Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Sabrina Müller, Tjalf Ziemssen, Curt Diehm, Tobias Duncker, Philipp Hoffmanns, Inga-Marion Thate-Waschke, Markus Schürks & Thomas Wilke. (2020) How to Implement Adherence-Promoting Programs in Clinical Practice? A Discrete Choice Experiment on Physicians’ Preferences. Patient Preference and Adherence 14, pages 267-276.
Read now
Read now
Articles from other publishers (18)
Alan Kivitz, Wesley DeHaan, Rehan Azeem, Justin Park, Sheri Rhodes, Jamie Inshaw, Sheldon S. Leung, Savvas Nicolaou, Lloyd Johnston, Takashi K. Kishimoto, Peter G. Traber, Earl Sands & Hyon Choi. (2023) Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110). Rheumatology and Therapy 10:4, pages 825-847.
Crossref
Crossref
Joondon Lee, Jinseok Kim, Byeongzu Ghang & Wooseong Jeong. (2023) A retrospective observational study of the appropriate starting dose of febuxostat in patients with gout. The Korean Journal of Internal Medicine 38:3, pages 427-433.
Crossref
Crossref
Joong Kyong Ahn. (2023) Epidemiology and treatment-related concerns of gout and hyperuricemia in Korean. Journal of Rheumatic Diseases 30:2, pages 88-98.
Crossref
Crossref
Enrique Calvo-Aranda, Fernando Manuel Sánchez-Aranda, Laura Cebrián Méndez, María de los Ángeles Matías de la Mano, Leticia Lojo Oliveira & María Teresa Navío Marco. (2022) Perceived quality in patients with gout treated in a rheumatology clinic with a clinical nurse specialist. Reumatología Clínica (English Edition) 18:10, pages 608-613.
Crossref
Crossref
Enrique Calvo-Aranda, Fernando Manuel Sánchez-Aranda, Laura Cebrián Méndez, María de los Ángeles Matías de la Mano, Leticia Lojo Oliveira & María Teresa Navío Marco. (2022) Estudio de calidad percibida en pacientes con gota atendidos en una consulta de reumatología con enfermería especializada. Reumatología Clínica 18:10, pages 608-613.
Crossref
Crossref
Aislinn F. Lalor, Joanne E. Brooker, Tomas Rozbroj, Samuel L. Whittle, Catherine L. Hill, Debra Rowett, Rachelle Buchbinder & Denise A. O'Connor. (2022) Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies. Seminars in Arthritis and Rheumatism 55, pages 151988.
Crossref
Crossref
Yasaman Emad, Nicola Dalbeth, John Weinman, Trudie Chalder & Keith J. Petrie. (2022) Why Do Patients With Gout Not Take Allopurinol?. The Journal of Rheumatology 49:6, pages 622-626.
Crossref
Crossref
Fernando Pérez Ruiz, Nuria Pérez Herrero & María Ángeles Gantes Pedraza. (2022) Gota. ¿Qué hay de nuevo, doctor?. Medicina Clínica 158:12, pages 615-621.
Crossref
Crossref
Fernando Pérez Ruiz, Nuria Pérez Herrero & María Ángeles Gantes Pedraza. (2022) Gout. What's up doc?. Medicina Clínica (English Edition) 158:12, pages 615-621.
Crossref
Crossref
Ritch te Kampe, Annelies Boonen, Tim L. Jansen, Jan Mathis Elling, Marcel Flendrie, Yvonne van Eijk-Hustings, Matthijs Janssen, Caroline van Durme & Hein de Vries. (2022) Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout. BMC Medical Informatics and Decision Making 22:1.
Crossref
Crossref
Ritch te Kampe, Tim L. Jansen, Caroline van Durme, Matthijs Janssen, Gudula Petersen & Annelies Boonen. (2022) Outcomes of Care Among Patients With Gout in Europe: A Cross-sectional Survey. The Journal of Rheumatology 49:3, pages 312-319.
Crossref
Crossref
Fernando Perez-Ruiz, Nuria Perez-Herrero, Pascal Richette & Austin G. Stack. (2020) High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who’s to Blame?. Rheumatology and Therapy 7:4, pages 1011-1019.
Crossref
Crossref
Aran Kim, Yunkyung Kim, Geun-Tae Kim, Eunyoung Ahn, Min Wook So & Seung-Geun Lee. (2020) Comparison of persistence rates between allopurinol and febuxostat as first-line urate-lowering therapy in patients with gout: an 8-year retrospective cohort study. Clinical Rheumatology 39:12, pages 3769-3776.
Crossref
Crossref
R. Kampe, C. Durme, M. Janssen, Y. Eijk‐Hustings, A. Boonen & T. L. Jansen. (2020) Comparative Study of Real‐Life Management Strategies in Gout: Data From Two Protocolized Gout Clinics. Arthritis Care & Research 72:8, pages 1169-1176.
Crossref
Crossref
Nicholas E. Powers, Benjamin Swartzwelter, Carlo Marchetti, Dennis M. de Graaf, Alexandra Lerchner, Martin Schlapschy, Rajiv Datar, Uli Binder, Carl K. EdwardsIIIIII, Arne Skerra & Charles A. Dinarello. (2020) PASylation of IL-1 receptor antagonist (IL-1Ra) retains IL-1 blockade and extends its duration in mouse urate crystal-induced peritonitis. Journal of Biological Chemistry 295:3, pages 868-882.
Crossref
Crossref
Irvin J. Huang, Jean W. Liew, Meredith B. Morcos, Silu Zuo, Carol Crawford & Alison M. Bays. (2019) Pharmacist-managed titration of urate-lowering therapy to streamline gout management. Rheumatology International 39:9, pages 1637-1641.
Crossref
Crossref
Keith R Martin & Katie M Coles. (2019) Consumption of 100% Tart Cherry Juice Reduces Serum Urate in Overweight and Obese Adults. Current Developments in Nutrition 3:5, pages nzz011.
Crossref
Crossref
Roland SeifertRoland Seifert. 2019. Basic Knowledge of Pharmacology. Basic Knowledge of Pharmacology
279
286
.